{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:13:08Z","timestamp":1778278388079,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ygyno.2026.02.014","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:39:47Z","timestamp":1772030387000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery"],"prefix":"10.1016","volume":"207","author":[{"given":"A. Rafael","family":"Guijarro-Campillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida","family":"Gonz\u00e1lez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gil-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Olivares-Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"S\u00e1nchez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer\u00f3nimo","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An\u00edbal","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Antonio","family":"Cascales-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2026.02.014_bb0005","article-title":"FIGO\u2019S staging classi cation forcancer of the ovary, fallopian tube, and peritoneum: abridged republication","volume":"26","author":"Prat","year":"2015","journal-title":"J. GynecolOncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0010","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.3802\/jgo.2018.29.e37","article-title":"Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer","volume":"29","author":"Hirose","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0015","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ejso.2021.04.003","article-title":"Total parietal peritonectomy performed during interval cytoreductive surgery for advanced epithelial serous ovarian Cancer results in a low incidence of platinum resistant recurrence- results of a prospective multi-Centre study","volume":"47","author":"Bhatt","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0020","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl. Cancer Inst. Monogr."},{"issue":"17","key":"10.1016\/j.ygyno.2026.02.014_bb0025","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Gynecologic Oncology group. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0030","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","article-title":"Fader and rose role of surgery in ovarian carcinoma","volume":"25","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-00009577-200305000-00005","article-title":"Can bowel endoscopy predict colorectal surgery in patients with an adnexal mass?","volume":"13","author":"Petru","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.02.014_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-002-1712-8","article-title":"Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer","volume":"13","author":"Ricke","year":"2003","journal-title":"Eur. Radiol."},{"issue":"12","key":"10.1016\/j.ygyno.2026.02.014_bb0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejso.2011.09.003","article-title":"Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome","volume":"37","author":"Gallotta","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2023.101946","article-title":"Surgical efficacy and quality of wide resection of the pelvic peritoneum in patients with epithelial ovarian cancer","volume":"48","author":"Nishimura","year":"2023","journal-title":"Surg. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.02.014_bb0055","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0000000000001368","article-title":"Rectosigmoidectomy and Douglas peritonectomy in the management of serosal implants in advanced-stage ovarian cancer surgery: survival and surgical outcomes","volume":"28","author":"Erkilin\u00e7","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2026.02.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.101973","article-title":"Surgical outcomes of rectosigmoid colon resection versus rectosigmoid wall stripping for superficial rectal wall tumors at cytoreductions for advanced ovarian cancer","volume":"35","author":"Bae","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.014_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2006.06.027","article-title":"Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer","volume":"203","author":"Aletti","year":"2006","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2023.10.002","article-title":"Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: a prospective longitudinal study","volume":"178","author":"Imterat","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.014_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.03.241","article-title":"Risk factors for anastomotic leakage aftercolorectal resection in ovarian cancer surgery: a multi-Centre study","volume":"153","author":"Lago","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.014_bb0080","doi-asserted-by":"crossref","DOI":"10.1006\/gyno.2001.6353","article-title":"Safety and ef cacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer","volume":"83","author":"Obermair","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0090","article-title":"Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer","volume":"7","author":"Coleridge","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9990","key":"10.1016\/j.ygyno.2026.02.014_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ygyno.2026.02.014_bb0105","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2026.02.014_bb0110","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(23)00396-0","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial","volume":"24","author":"Aronson","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0115","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1245\/s10434-021-11087-7","article-title":"Cytoreductive surgery with or without HIPEC after neoadjuvant chemotherapy in ovarian cancer: a phase 3 clinical trial","volume":"29","author":"Antonio","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"HIPEC for ovarian cancer collaborators. Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.6004\/jnccn.2019.0039","article-title":"NCCN guidelines insights: ovarian cancer, version 1.2019","volume":"17","author":"Armstrong","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA5500","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"43","author":"Mahner","year":"2025","journal-title":"JCO"},{"key":"10.1016\/j.ygyno.2026.02.014_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejso.2002.1380","article-title":"Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer","volume":"29","author":"Tentes","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.014_bb0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0140","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1245\/s10434-014-3599-4","article-title":"Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer","volume":"21","author":"Cascales-Campos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.02.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf112","article-title":"PSOGI-ESGO-ISSPP Collaborators. Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensus","volume":"112","author":"Bhatt","year":"2025","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0150","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-0528.1968.tb02901.x","article-title":"A radical operation for fixed ovarian tumours","volume":"75","author":"Hudson","year":"1968","journal-title":"J. Obstet. Gynaecol. Br. Commonw."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0155","author":"National Cancer Institute, Cancer Therapy Evaluation Program"},{"key":"10.1016\/j.ygyno.2026.02.014_bb0160","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1007\/s12094-025-03927-9","article-title":"Peritoneal cancer index in ovarian cancer: what does the surgeon really see?","author":"L\u00f3pez-Hern\u00e1ndez","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2012.11.007","article-title":"Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?","volume":"128","author":"Hynninen","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.014_bb0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40477-025-01061-4","article-title":"Intraoperative transvaginal ultrasound: a novel approach to refine surgical strategy in rectosigmoid endometriosis surgery","volume":"7","author":"Hurni","year":"2025","journal-title":"J. Ultrasound."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2026.04.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826008085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:14:08Z","timestamp":1774314848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826008085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":34,"alternative-id":["S0090825826008085"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}